Skip to content
Search

Latest Stories

Pharmacist Sadik Al-Hassan secures historic win for Labour Party in North Somerset

Pharmacist Sadik Al-Hassan secures historic win for Labour Party in North Somerset
Pharmacist and newly elected Member of Parliament Sadik Al-Hassan secured victory with 19,138 votes, propelled by a substantial surge in Labour voters

In a remarkable political shift, community pharmacist, Sadik Al-Hassan has been elected as the first Labour MP for North Somerset, toppling Liam Fox's long-standing Conservative stronghold.

This victory ends Fox’s 32-year tenure, overturning his previous majority of 17,536 votes.


Al-Hassan, who is the superintendent of online pharmacy PillTime, won the seat with 19,138 votes, thanks to a significant Labour landslide.

Sadik Al-Hassan, a pharmacist from Patchway, campaigned on key issues such as revitalising the NHS, improving local services, and environmental protection.

During the campaign, Al-Hassan emphasised his dedication to the community, citing his work as a local pharmacist during the pandemic and his tenure as Deputy Mayor in Emerson’s Green.

“It’s time for a new approach to healthcare in North Somerset — one where vital services are properly staffed and funded and more services are delivered in local communities,” Al-Hassan had remarked during his visit in Portishead’s West Hill pharmacy on June 20.

He focused on addressing local concerns, including better neighborhood policing, reliable public transport, and protecting green spaces from environmental damage.

“As a local pharmacist, I have been privileged to work in some of North Somerset’s brilliant pharmacies, including the two Day Lewis pharmacies in Nailsea and the West Hill pharmacy in Portishead, so I know how hard it is on the NHS front line,”

Pharmacies like those in Nailsea, Clevedon, and Portishead are being asked to deliver more services, but the funding doesn’t support them, putting this vital community service at risk.”

Statistics highlight North Somerset's struggles to meet key healthcare targets, including ambulance arrivals, A&E waiting times, and GP appointments .

Following a hard-fought campaign that saw Liam Fox booted out as an MP, Al-Hassan took to social media X, formerly Twitter to express his gratitude and commitment to the community, stating:

"I am truly honoured to be elected as the first Labour Member of Parliament for North Somerset."

Royal Pharmaceutical Society (RPS) President Professor Claire Anderson welcomed Al-Hassan’s election, emphasising the vital role pharmacists will play in the future of healthcare.

She also took the opportunity to congratulate former Chair of the All-Party Parliamentary Group for Pharmacy, Taiwo Owatemi, for having retained her seta in Coventry North West.

Calling for sustainable funding to support pharmacists in reducing health inequalities and managing long-term conditions, Anderson said:

"It's fantastic we now have two pharmacists elected to Parliament. We look forward to working with both of them.

“The future of our health service has been at the forefront of the election campaign and, amid workforce shortages and medicines supply issues, the new Government must turn its attention to enhancing patient care in a health service under continued pressure.

“Pharmacists will be central to reducing health inequalities, managing the growing cost of long-term conditions, and delivering best value from medicines for patients and the NHS.

“As pharmacists are asked to do more, this must be backed by sustainable funding, and I look forward to working with the Government on how to make the best use of pharmacists’ skills to benefit patients, including through the growing number of pharmacist prescribers.

“The Health Select Committee set out clear priorities for pharmacy in its latest report and I would urge the new Government to act on its recommendations."

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less